Picture of the Month—Diagnosis | Cerebrovascular Disease | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Sign In
Citations 0
Special Feature
February 2, 2009

Picture of the Month—Diagnosis

Arch Pediatr Adolesc Med. 2009;163(2):180. doi:10.1001/archpediatrics.2008.520-b

Denouement and Comment: Moyamoya Disease

Moyamoya disease is a chronic cerebrovascular condition in which internal carotid artery or its terminal branches occlude progressively. New vessels develop, which bypass the stenotic arteries of the circle of Willis, creating a rich network of small fragile arteries. The dense angiographic appearance of newly formed collaterals is the hallmark of moyamoya, a Japanese term meaning “hazy, like a puff of smoke.”

Moyamoya disease is rare, with an incidence of 0.35 to 0.54 per 100 000 people in Asia,1-3whereas its incidence is much lower in Western countries.3It has a female predominance of 1.8:1,1which is less evident at younger ages.4

Secondary moyamoya disease has been associated with neurofibromatosis type 1, Down syndrome, fibromuscular dysplasia, congenital heart disease, cranial radiotherapy, intrathecal chemotherapy, sickle cell disease,5and others. However, most cases are idiopathic, and a genetic origin may be present, as indicated by a higher prevalence in people of Asian descent3and by the occurrence of familial cases in approximately 10% of patients.

Clinical presentation is age dependent. Children usually present with an ischemic stroke and seizures rather than with hemorrhagic stroke. Adults typically present with hemorrhagic stroke more often than ischemic stroke and only rarely with seizures.5,6In children and adults, other symptoms can include recurrent transient ischemic events and migrainelike headaches.

The diagnosis of moyamoya disease is a clinicoradiologic one; a history of acute neurologic deficits with the characteristic angiographic image is diagnostic. Magnetic resonance imaging reveals acute and chronic strokes. Although the magnetic resonance angiogram may suggest moyamoya disease, as in our case, the criterion standard for the diagnosis remains conventional arterial angiography.

Several medical treatments, such as corticosteroids, calcium channel blockers, anticoagulants, and antiplatelet drugs, have been used with only limited benefit, reported in individual cases, whereas no controlled studies have been performed.7,8The most promising treatment of moyamoya disease is surgical, consisting of a bypass between the external and internal carotid systems. This can be achieved by a direct revascularization technique, such as superficial temporal artery to middle cerebral artery anastomosis, or by an indirect bypass, such as a pial synangiosis. Data are scant comparing results after different surgical approaches, so there is no universally accepted technique,4,5,9but indirect revascularization is generally preferred in children.

The prognosis of this disease is age related; the younger the patient, the worse the outcome. A favorable prognosis is found in 53% to 58% of patients 3 years or younger4,5compared with an 86% favorable prognosis in children older than 6 years.4As noted by Scott et al,5prognosis is also related to functional status at the time of surgery.

Our patient had a common presentation of moyamoya disease in children, with abrupt-onset seizures and recurrent ischemic strokes, but at an exceptionally young age. Our diagnostic assumption was confirmed by the angiogram (Figure 2). The classic “puff of smoke” can be seen at the end of the internal carotid artery (center of image), which is totally occluded without blood flow in the anterior cerebral artery and middle cerebral artery. An extensive collateral vessel network is noted. Of interest is the ophthalmic artery, the vessel on the far left of the image, which is recruited in the collateral circulation.

Figure 2. 
Arterial angiogram of the left internal carotid system. Findings are described in detail in the “Denouement and Comment” section.

Arterial angiogram of the left internal carotid system. Findings are described in detail in the “Denouement and Comment” section.

Our patient had poor functional status before surgery at age 13 months, with difficult-to-control seizures and the neurologic sequelae of 2 strokes. Pial synangiosis was performed without perioperative complications. However, on day 1 after surgery, the patient had a new catastrophic ischemic stroke, this time involving the entire right middle cerebral artery territory with resultant midline shift and uncal herniation. His prognosis was guarded, and in accordance with the family's directives, palliative care was initiated.

The interest of this case lies in 3 aspects. First, the young age on first presentation of our patient is rare and supplements previous case reports with onset of the disease at 410and 2½11months of age. Second, it reinforces that young age at onset and poor functional status before surgery are risk factors for poor outcome. Third, it underlines the importance of considering vessel imaging studies in patients of Asian descent who present with acute symptomatic seizures and stroke.

Return to Quiz Case.

Correspondence:Iván Sánchez Fernández, MD, Passeig Sant Joan de Déu, 2 Esplugues de Llobregat, 08950, Barcelona, Spain (isanchez@hsjdbcn.org).

Accepted for Publication:September 10, 2008.

Author Contributions:Study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, and administrative, technical, and material support: Sánchez Fernández and Peters. Study supervision: Peters.

Financial Disclosure:None reported.

Kuriyama  SKusaka  YFujimura  M  et al.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan.  Stroke 2008;39 (1) 42- 47PubMedGoogle ScholarCrossref
Wakai  KTamakoshi  AIkezaki  K  et al.  Epidemiological features of moyamoya disease in Japan.  Clin Neurol Neurosurg 1997;99 ((suppl 2)) S1- S5PubMedGoogle ScholarCrossref
Uchino  KJohnston  SCBecker  KJTirschwell  DL Moyamoya disease in Washington State and California.  Neurology 2005;65 (6) 956- 958PubMedGoogle ScholarCrossref
Kim  SKSeol  HJCho  BKHwang  YSLee  DSWang  KC Moyamoya disease among young patients.  Neurosurgery 2004;54 (4) 840- 846PubMedGoogle ScholarCrossref
Scott  RMSmith  JLRobertson  RLMadsen  JRSoriano  SGRockoff  MA Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.  J Neurosurg 2004;100 (2) ((suppl Pediatrics)) 142- 149PubMedGoogle Scholar
Suzuki  JKodama  N Moyamoya disease: a review.  Stroke 1983;14 (1) 104- 109PubMedGoogle ScholarCrossref
Hosain  SAHughes  JTForem  SLWisoff  JFish  I Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease.  J Child Neurol 1994;9 (4) 378- 380PubMedGoogle ScholarCrossref
McLean  MJGebarski  SSvan der Spek  AFGoldstein  GW Response of moyamoya disease to verapamil.  Lancet 1985;1 (8421) 163- 164PubMedGoogle ScholarCrossref
Sainte-Rose  COliveira  RPuget  S  et al.  Multiple burr hole surgery for the treatment of moyamoya disease in children.  J Neurosurg 2006;105 (6) ((suppl)) 437- 443PubMedGoogle Scholar
Sribnick  EAGoldblatt  MRCampbell  JWRoberts  JR Moyamoya disease in a four-month-old: a case study.  Clin Pediatr (Phila) 2003;42 (3) 281- 284PubMedGoogle ScholarCrossref
Welch  WCMcBride  MKido  DKNelson  CN Moyamoya disease in an infant with autonomic dysfunction.  J Child Neurol 1988;3 (2) 110- 113PubMedGoogle ScholarCrossref